Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions

World Journal of Clinical Oncology

Volumn 6, Issue 5, 2015, Pages 111-132

  Libânio, Diogo ^a,b   Dinis Ribeiro, Mário ^a,b   Pimentel Nunes, Pedro ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b University of Porto   (Portugal)

Author keywords

DNA methylation; Gastric cancer; Helicobacter pylori; Immune response; Inflammation; MicroRNA; Preneoplastic conditions; Stomach neoplasms

Indexed keywords

EID: 84945124986     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v6.i5.111     Document Type: Review

References (205)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 2009; 15: 971-976 [PMID: 19874380 DOI: 10.1111/j.1469-0691.2009.03031.x]
3. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560 [PMID: 3288329]
4. Lee Y, Han J, Yeom KH, Jin H, Kim VN. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 2006; 71: 51-57 [PMID: 17381280 DOI: 10.1101/sqb.2006.71.041]
5. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha- DGCR8 complex in primary microRNA processing. Genes Dev 2004; 18: 3016-3027 [PMID: 15574589 DOI: 10.1101/gad.1262 504]
6. Lund E, Güttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303: 95-98 [PMID: 14631048 DOI: 10.1126/science.1090599]
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
8. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006; 126: 1203-1217 [PMID: 16990141 DOI: 10.1016/j. cell.2006.07.031]
9. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372-379 [PMID: 18449891 DOI: 10.1002/ijc.23501]
10. Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H, Hibi T. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 2012; 7: e47396 [PMID: 23209550 DOI: 10.1371/journal.pone.0047396]
11. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011; 128: 361-370 [PMID: 20333682 DOI: 10.1002/ ijc.25348]
12. Zabaleta J. MicroRNA: A Bridge from H. pylori Infection to Gastritis and Gastric Cancer Development. Front Genet 2012; 3: 294 [PMID: 23248648 DOI: 10.3389/fgene.2012.00294]
13. Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activationinduced proliferation of human T and B lymphocyte subsets. J Immunol 2007; 179: 5433-5440 [PMID: 17911630]
14. Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol 2011; 1: 21 [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021]
15. Polk DB, Peek RM. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10: 403-414 [PMID: 20495574 DOI: 10.1038/nrc2857]
16. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochem Pharmacol 2007; 73: 1697-1702 [PMID: 17134680 DOI: 10.1016/ j.bcp.2006.10.022]
17. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434 [PMID: 12775840 DOI: 10.1126/science.1081919]
18. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, Ohno S, Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-333 [PMID: 17507984 DOI: 10.1038/nature05765]
19. Zhu Y, Zhong X, Zheng S, Du Q, Xu W. Transformed immortalized gastric epithelial cells by virulence factor CagA of Helicobacter pylori through Erk mitogen-activated protein kinase pathway. Oncogene 2005; 24: 3886-3895 [PMID: 15856031 DOI: 10.1038/ sj.onc.1208551]
20. Lamb A, Chen LF. The many roads traveled by Helicobacter pylori to NFκB activation. Gut Microbes 2010; 1: 109-113 [PMID: 21326919 DOI: 10.4161/gmic.1.2.11587]
21. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman RH, Kersulyte D, Berg DE, Sasakawa C. Helicobacter pylori CagA phosphorylationindependent function in epithelial proliferation and inflammation. Cell Host Microbe 2009; 5: 23-34 [PMID: 19154985 DOI: 10.1016/ j.chom.2008.11.010]
22. Backert S, Naumann M. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010; 18: 479-486 [PMID: 20863705 DOI: 10.1016/ j.tim.2010.08.003]
23. Sepulveda AR, Yao Y, Yan W, Park DI, Kim JJ, Gooding W, Abudayyeh S, Graham DY. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology 2010; 138: 1836-1844 [PMID: 20044995 DOI: 10.1053/j.gastro.2009.12.042]
24. Sepulveda AR. Helicobacter, Inflammation, and Gastric Cancer. Curr Pathobiol Rep 2013; 1: 9-18 [PMID: 23687623 DOI: 10.1007/ s40139-013-0009-8]
25. Leung WK, Kim JJ, Kim JG, Graham DY, Sepulveda AR. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol 2000; 156: 537-543 [PMID: 10666383 DOI: 10.1016/S0002-9440(10)64758-X]
26. Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med 2005; 25: 197-222 [PMID: 15749238 DOI: 10.1016/ j.cll.2004.12.002]
27. Park SY, Yoo EJ, Cho NY, Kim N, Kang GH. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol 2009; 219: 410-416 [PMID: 19639607 DOI: 10.1002/path.2596]
28. Sepulveda AR, Jones D, Ogino S, Samowitz W, Gulley ML, Edwards R, Levenson V, Pratt VM, Yang B, Nafa K, Yan L, Vitazka P. CpG methylation analysis- current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. J Mol Diagn 2009; 11: 266-278 [PMID: 19541921 DOI: 10.2353/jmoldx.2009.080125]
29. Pasechnikov VD, Chukov SZ. [Inflammatory and immune responses of gastric mucosa on Helicobacter pylori infection]. Klin Med (Mosk) 2000; 78: 9-13 [PMID: 11232538]
30. Belair C, Darfeuille F, Staedel C. Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 2009; 15: 806-812 [PMID: 19702585 DOI: 10.1111/j.1469-0691.2009.02960.x]
31. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Mémet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174 [PMID: 15489856 DOI: 10.1038/ni1131]
32. Oghumu S, Satoskar A. The emerging role of dendritic cells in the host immune response against Helicobacter pylori. Front Microbiol 2014; 5: 560 [PMID: 25386172 DOI: 10.3389/fmicb.2014.00560]
33. Ferrero RL. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori. Mol Immunol 2005; 42: 879-885 [PMID: 15829277 DOI: 10.1016/j.molimm.2004.12.001]
34. Rad R, Ballhorn W, Voland P, Eisenächer K, Mages J, Rad L, Ferstl R, Lang R, Wagner H, Schmid RM, Bauer S, Prinz C, Kirschning CJ, Krug A. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology 2009; 136: 2247-2257 [PMID: 19272387 DOI: 10.1053/j.gastro.2009.02.066]
35. Hocès de la Guardia A, Staedel C, Kaafarany I, Clément A, Roubaud Baudron C, Mégraud F, Lehours P. Inflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strains. Front Microbiol 2013; 4: 236 [PMID: 23970881 DOI: 10.3389/fmicb.2013.00236]
36. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998; 160: 2401-2407 [PMID: 9498783]
37. Allison CC, Kufer TA, Kremmer E, Kaparakis M, Ferrero RL. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J Immunol 2009; 183: 8099-8109 [PMID: 20007577 DOI: 10.4049/jimmunol.090066 4]
38. Moran AP. Helicobacter pylori lipopolysaccharide-mediated gastric and extragastric pathology. J Physiol Pharmacol 1999; 50: 787-805 [PMID: 10695559]
39. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692 [PMID: 10196138]
40. Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010; 78: 845-853 [PMID: 19917709 DOI: 10.1128/IAI.00524-09]
41. Fehlings M, Drobbe L, Moos V, Renner Viveros P, Hagen J, Beigier-Bompadre M, Pang E, Belogolova E, Churin Y, Schneider T, Meyer TF, Aebischer T, Ignatius R. Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. Infect Immun 2012; 80: 2724-2734 [PMID: 22615251 DOI: 10.1128/IAI.00381-12]
42. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054 [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043]
43. Wang YH, Wu JJ, Lei HY. When Helicobacter pylori invades and replicates in the cells. Autophagy 2009; 5: 540-542 [PMID: 19270492]
44. Terebiznik MR, Vazquez CL, Torbicki K, Banks D, Wang T, Hong W, Blanke SR, Colombo MI, Jones NL. Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect Immun 2006; 74: 6599-6614 [PMID: 17000720 DOI: 10.1128/IAI.01085-06]
45. Wang YH, Wu JJ, Lei HY. The autophagic induction in Helicobacter pylori-infected macrophage. Exp Biol Med (Maywood) 2009; 234: 171-180 [PMID: 19064937 DOI: 10.3181/0808-RM-252]
46. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 666-673 [PMID: 19382179 DOI: 10.1002/ijc.24290]
47. Walsh-Reitz MM, Huang EF, Musch MW, Chang EB, Martin TE, Kartha S, Toback FG. AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2005; 289: G163-G171 [PMID: 15961882 DOI: 10.1152/ajpgi.00013.2005]
48. Yoon JH, Cho ML, Choi YJ, Back JY, Park MK, Lee SW, Choi BJ, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem 2013; 114: 1800-1809 [PMID: 23444260 DOI: 10.1002/jcb.24524]
49. Nardone G, Martin G, Rocco A, Rippa E, La Monica G, Caruso F, Arcari P. Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions. Cancer Biol Ther 2008; 7: 1890-1895 [PMID: 18927498]
50. Mao W, Chen J, Peng TL, Yin XF, Chen LZ, Chen MH. Downregulation of gastrokine-1 in gastric cancer tissues and restoration of its expression induced gastric cancer cells to apoptosis. J Exp Clin Cancer Res 2012; 31: 49 [PMID: 22621392 DOI: 10.1186/17 56-9966-31-49]
51. Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA. Carcinogenesis 2014; 35: 2619-2629 [PMID: 25239641 DOI: 10.1093/carcin/bgu199]
52. Yoon JH, Choi WS, Kim O, Park WS. The role of gastrokine 1 in gastric cancer. J Gastric Cancer 2014; 14: 147-155 [PMID: 25328759 DOI: 10.5230/jgc.2014.14.3.147]
53. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444 [PMID: 18650914 DOI: 10.1038/nature07205]
54. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NFkappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-466 [PMID: 15329734 DOI: 10.1038/nature02924]
55. Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143: 550-563 [PMID: 22796521 DOI: 10.1053/j.gastro.2012.07.009]
56. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T, Fujimori T. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 2008; 29: 76-83 [PMID: 18024479 DOI: 10.1093/carcin/bgm250]
57. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF- κB as the matchmaker. Nat Immunol 2011; 12: 715-723 [PMID: 21772280 DOI: 10.1038/ni.2060]
58. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 2003; 71: 3496-3502 [PMID: 12761134]
59. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Müller-Hermelink HK, Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526 [PMID: 15147355 DOI: 10.1111/j.136 5-2249.2004.02464.x]
60. Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 2008; 27: 234-243 [PMID: 18176605 DOI: 10.1038/sj.onc.1210908]
61. Pimentel-Nunes P, Afonso L, Lopes P, Roncon-Albuquerque R, Gonçalves N, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 2011; 17: 677-683 [PMID: 21455638 DOI: 10.1007/s12253-011-9368-9]
62. Pimentel-Nunes P, Gonçalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque R, Henrique R, Moreira-Dias L, Leite-Moreira AF, Dinis-Ribeiro M. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Tollinteracting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2013; 18: 22-32 [PMID: 23061653 DOI: 10.1111/hel.12008]
63. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86 [PMID: 14657504 DOI: 10.1126/science.1091903]
64. Cadamuro AC, Rossi AF, Maniezzo NM, Silva AE. Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs. World J Gastroenterol 2014; 20: 1424-1437 [PMID: 24587619 DOI: 10.3748/wjg.v20.i6.1424]
65. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261 [PMID: 16461460 DOI: 10.1073/pnas.0510565103]
66. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88: 1358-1366 [PMID: 18794849 DOI: 10.1038/ labinvest.2008.94]
67. Isomoto H, Matsushima K, Inoue N, Hayashi T, Nakayama T, Kunizaki M, Hidaka S, Nakayama M, Hisatsune J, Nakashima M, Nagayasu T, Nakao K, Hirayama T. Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection. J Clin Immunol 2012; 32: 290-299 [PMID: 22161133 DOI: 10.1007/s10875-011-9626-3]
68. Roush S, Slack FJ. The let-7 family of microRNAs. Trends Cell Biol 2008; 18: 505-516 [PMID: 18774294 DOI: 10.1016/ j.tcb.2008.07.007]
69. Teng GG, Wang WH, Dai Y, Wang SJ, Chu YX, Li J. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4. PLoS One 2013; 8: e56709 [PMID: 23437218 DOI: 10.1371/journal. pone.0056709]
70. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol 2007; 13: 2883-2888 [PMID: 17569129]
71. Kong D, Piao YS, Yamashita S, Oshima H, Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, Satou K, Ushijima T, Ishikawa TO, Oshima M. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 2012; 31: 3949-3960 [PMID: 22139078 DOI: 10.1038/onc.2011.558]
72. Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, Jin Y, Li W, Nakamura T, Nishida T, Iijima H, Tsuji S, Kawano S, Hayashi N, Takehara T. CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut 2013; 62: 1536-1546 [PMID: 22936674 DOI: 10.1136/gutjnl- 2011-30162 5]
73. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ, Jimenez P, Rodriguez J, Garcia-Foncillas J. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009; 15: 2281-2290 [PMID: 19318487 DOI: 10.1158/1078-0432.CCR-08-1818]
74. Smolka AJ, Backert S. How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol 2012; 47: 609-618 [PMID: 22565637 DOI: 10.1007/s00535-012-0592-1]
75. Zhang YM, Noto JM, Hammond CE, Barth JL, Argraves WS, Backert S, Peek RM, Smolka AJ. Helicobacter pylori-induced posttranscriptional regulation of H-K-ATPase α-subunit gene expression by miRNA. Am J Physiol Gastrointest Liver Physiol 2014; 306: G606-G613 [PMID: 24503769 DOI: 10.1152/ajpgi.0033 3.2013]
76. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011; 11: 163-175 [PMID: 21331081 DOI: 10.1038/nri2957]
77. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609 [PMID: 17242365 DOI: 10.1073/pnas.0610731104]
78. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNFalpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082-5089 [PMID: 17911593]
79. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486 [PMID: 16885212 DOI: 10.1073/ pnas.0605298103]
80. Liu Z, Xiao B, Tang B, Li B, Li N, Zhu E, Guo G, Gu J, Zhuang Y, Liu X, Ding H, Zhao X, Guo H, Mao X, Zou Q. Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect 2010; 12: 854-863 [PMID: 20542134 DOI: 10.1016/ j.micinf.2010.06.002]
81. Li N, Xu X, Xiao B, Zhu ED, Li BS, Liu Z, Tang B, Zou QM, Liang HP, Mao XH. H. pylori related proinflammatory cytokines contribute to the induction of miR-146a in human gastric epithelial cells. Mol Biol Rep 2012; 39: 4655-4661 [PMID: 21947847 DOI: 10.1007/s11033-011-1257-5]
82. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A, Baltimore D, Rudensky AY. Function of miR- 146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142: 914-929 [PMID: 20850013 DOI: 10.1016/j. cell.2010.08.012]
83. Liu Z, Wang D, Hu Y, Zhou G, Zhu C, Yu Q, Chi Y, Cao Y, Jia C, Zou Q. MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells. J Gastroenterol 2013; 48: 86-92 [PMID: 22699322 DOI: 10.1007/ s00535-012-0609-9]
84. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 1218-1223 [PMID: 10235197 DOI: 10.1111/j. 1572-0241. 1999.01070.x]
85. Koch M, Mollenkopf HJ, Klemm U, Meyer TF. Induction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci USA 2012; 109: E1153-E1162 [PMID: 22509021 DOI: 10.1073/pnas.1116125109]
86. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009; 200: 916-925 [PMID: 19650740 DOI: 10.1086/605443]
87. Tang B, Xiao B, Liu Z, Li N, Zhu ED, Li BS, Xie QH, Zhuang Y, Zou QM, Mao XH. Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pyloriinduced inflammation. FEBS Lett 2010; 584: 1481-1486 [PMID: 20219467 DOI: 10.1016/j.febslet.2010.02.063]
88. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA, Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 2009; 106: 2735-2740 [PMID: 19193853 DOI: 10.1073/pnas.0811073106]
89. Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, Wu C, Mao XH, Jia KR, Wang FJ, Guo H, Flavell RA, Zhao Z, Liu KY, Xiao B, Guo Y, Zhang WJ, Zhou WY, Guo G, Zou QM. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 2010; 184: 5121-5129 [PMID: 20351183 DOI: 10.4049/ jimmunol.0901115]
90. Oertli M, Engler DB, Kohler E, Koch M, Meyer TF, Müller A. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J Immunol 2011; 187: 3578-3586 [PMID: 21880981 DOI: 10.4049/jimmunol.1101772]
91. Lv X, Yang J, Song H, Li T, Guo L, Xing Y, Xi T. Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA- 155-associated immuno-protective mechanism. Vaccine 2014; 32: 5343-5352 [PMID: 25093281 DOI: 10.1016/j.vaccine.2014.07.041]
92. Lv X, Song H, Yang J, Li T, Xi T, Xing Y. A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model. Hum Vaccin Immunother 2014; 10: 3561-3569 [PMID: 25483699 DOI: 10.4161/hv.36096]
93. Tang B, Li N, Gu J, Zhuang Y, Li Q, Wang HG, Fang Y, Yu B, Zhang JY, Xie QH, Chen L, Jiang XJ, Xiao B, Zou QM, Mao XH. Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori. Autophagy 2012; 8: 1045-1057 [PMID: 22647547 DOI: 10.4161/auto.20159]
94. Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta 2013; 424: 53-65 [PMID: 23669186 DOI: 10.1016/ j.cca.2013.05.002]
95. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989-995 [PMID: 16467114 DOI: 10.1158/1078-0432.CCR-05-2096]
96. Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, Sugiyama T, Ushijima T. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009; 124: 2367-2374 [PMID: 19165869 DOI: 10.1002/ijc.24219]
97. Niwa T, Tsukamoto T, Toyoda T, Mori A, Tanaka H, Maekita T, Ichinose M, Tatematsu M, Ushijima T. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70: 1430-1440 [PMID: 20124475 DOI: 10.1158/0008-5472.CAN-09-2755]
98. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-2851 [PMID: 11306456]
99. Calcagno DQ, Gigek CO, Chen ES, Burbano RR, Smith Mde A. DNA and histone methylation in gastric carcinogenesis. World J Gastroenterol 2013; 19: 1182-1192 [PMID: 23482412 DOI: 10.3748/wjg.v19.i8.1182]
100. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006; 55: 463-468 [PMID: 16428266 DOI: 10.1136/gut.2005.077776]
101. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in nonneoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-1371 [PMID: 17509026 DOI: 10.1111/j.1572-0241.2007.01284.x]
102. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309-313 [PMID: 10495421]
103. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6: 107-116 [PMID: 16491070 DOI: 10.1038/nrc1799]
104. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002; 161: 399-403 [PMID: 12163364 DOI: 10.1016/S0002-9440(10)64195-8]
105. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 2003; 94: 360-364 [PMID: 12824905]
106. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843 [PMID: 15944709 DOI: 10.1038/nature03677]
107. Tang X, Wen S, Zheng D, Tucker L, Cao L, Pantazatos D, Moss SF, Ramratnam B. Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One 2013; 8: e72503 [PMID: 24009686 DOI: 10.1371/journal.pone.0072503]
108. Saito Y, Suzuki H, Hibi T. The role of microRNAs in gastrointestinal cancers. J Gastroenterol 2009; 44 Suppl 19: 18-22 [PMID: 19148788 DOI: 10.1007/s00535-008-2285-3]
109. Kiga K, Mimuro H, Suzuki M, Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki YW, Kayo H, Fukuda- Yuzawa Y, Yashiro M, Fukayama M, Fukao T, Sasakawa C. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun 2014; 5: 4497 [PMID: 25187177 DOI: 10.1038/ ncomms5497]
110. Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J, Tao H, Jiang T, He W, Wang C, Du Q, Zheng S, Mao J, Huang J. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells. PLoS One 2012; 7: e35147 [PMID: 22536353 DOI: 10.1371/journal.pone.0035147]
111. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67: 1424-1429 [PMID: 17308079 DOI: 10.1158/0008-5472. CAN-06-4218]
112. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y. Methylation-associated silencing of microRNA- 34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis 2010; 31: 2066-2073 [PMID: 20924086 DOI: 10.1093/carcin/bgq203]
113. Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh SM, Song KS, Kim JC, Kim YS. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011; 6: 740-751 [PMID: 21562367]
114. Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res 2013; 19: 4599-4610 [PMID: 23846337 DOI: 10.1158/1078-0432.CCR-12-3675]
115. Choi WS, Seo HS, Song KY, Yoon JH, Kim O, Nam SW, Lee JY, Park WS. Gastrokine 1 expression in the human gastric mucosa is closely associated with the degree of gastritis and DNA methylation. J Gastric Cancer 2013; 13: 232-241 [PMID: 24511419 DOI: 10.5230/jgc.2013.13.4.232]
116. Tan Z, Jiang H, Wu Y, Xie L, Dai W, Tang H, Tang S. miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol Cell Biochem 2014; 386: 223-231 [PMID: 24352663 DOI: 10.1007/s11010-013-1860-y]
117. Shiotani A, Uedo N, Iishi H, Murao T, Kanzaki T, Kimura Y, Kamada T, Kusunoki H, Inoue K, Haruma K. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. J Gastroenterol 2012; 47: 988-998 [PMID: 22382634 DOI: 10.1007/s00535-012-0562-7]
118. Wang XW, Wu Y, Wang D, Qin ZF. MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer. Genet Mol Res 2014; 13: 8695-8703 [PMID: 25366760 DOI: 10.4238/2014.October.27.10]
119. Zhang L, Wang X, Chen P. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells. BMC Cancer 2013; 13: 290 [PMID: 23768087 DOI: 10.1186/1471-2407-13-290]
120. Petrocca F, Vecchione A, Croce CM. Emerging role of miR- 106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008; 68: 8191-8194 [PMID: 18922889 DOI: 10.1158/0008-5472.CAN-08-1768]
121. Zhu M, Zhang N, He S. Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development. Pathol Res Pract 2014; 210: 909-915 [PMID: 25115709 DOI: 10.1016/j.prp.2014.07.008]
122. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, Li D, Zhong J. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 2009; 400: 97-102 [PMID: 18996365 DOI: 10.1016/j.cca.2008.10.021]
123. Noto JM, Piazuelo MB, Chaturvedi R, Bartel CA, Thatcher EJ, Delgado A, Romero-Gallo J, Wilson KT, Correa P, Patton JG, Peek RM. Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1. Am J Physiol Gastrointest Liver Physiol 2013; 305: G786-G796 [PMID: 24136787 DOI: 10.1152/ajpgi.00279.2013]
124. Zhou X, Xia Y, Li L, Zhang G. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol Ther 2015; 16: 160-169 [PMID: 25561270 DOI: 10.4161/15384047.2014.987523]
125. Shen J, Xiao Z, Wu WK, Wang MH, To KF, Chen Y, Yang W, Li MS, Shin VY, Tong JH, Kang W, Zhang L, Li M, Wang L, Lu L, Chan RL, Wong SH, Yu J, Chan MT, Chan FK, Sung JJ, Cheng AS, Cho CH. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pyloriinduced gastric carcinogenesis. Cancer Res 2015; 75: 754-765 [PMID: 25503559 DOI: 10.1158/0008-5472.CAN-14-1301]
126. Feng Y, Wang L, Zeng J, Shen L, Liang X, Yu H, Liu S, Liu Z, Sun Y, Li W, Chen C, Jia J. FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res 2013; 11: 834-844 [PMID: 23576572 DOI: 10.1158/1541-7786.MCR-13-0007]
127. Li SP, Chen XJ, Sun AH, Zhao JF, Yan J. CagA(+) H. pylori induces Akt1 phosphorylation and inhibits transcription of p21(WAF1/CIP1) and p27(KIP1) via PI3K/Akt1 pathway. Biomed Environ Sci 2010; 23: 273-278 [PMID: 20934114 DOI: 10.1016/ S0895-3988(10)60063-3]
128. Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW. Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma. Oncogene 2012; 31: 226-237 [PMID: 21666718 DOI: 10.1038/onc.2011.226]
129. Nomura S, Baxter T, Yamaguchi H, Leys C, Vartapetian AB, Fox JG, Lee JR, Wang TC, Goldenring JR. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice. Gastroenterology 2004; 127: 582-594 [PMID: 15300590]
130. Nozaki K, Ogawa M, Williams JA, Lafleur BJ, Ng V, Drapkin RI, Mills JC, Konieczny SF, Nomura S, Goldenring JR. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology 2008; 134: 511-522 [PMID: 18242217 DOI: 10.1053/j.gastro.2007.11.058]
131. Bessède E, Dubus P, Mégraud F, Varon C. Helicobacter pylori infection and stem cells at the origin of gastric cancer. Oncogene 2015; 34: 2547-2555 [PMID: 25043305 DOI: 10.1038/onc.2014.187]
132. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011; 19: 387-400 [PMID: 21397861 DOI: 10.1016/j.ccr.2011.01.038]
133. Wada T, Ishimoto T, Seishima R, Tsuchihashi K, Yoshikawa M, Oshima H, Oshima M, Masuko T, Wright NA, Furuhashi S, Hirashima K, Baba H, Kitagawa Y, Saya H, Nagano O. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci 2013; 104: 1323-1329 [PMID: 23848514 DOI: 10.1111/cas.12236]
134. Ishimoto T, Izumi D, Watanabe M, Yoshida N, Hidaka K, Miyake K, Sugihara H, Sawayama H, Imamura Y, Iwatsuki M, Iwagami S, Baba Y, Horlad H, Komohara Y, Takeya M, Baba H. Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa. J Gastroenterol 2015; 50: 751-757 [PMID: 25479940 DOI: 10.1007/s00535-014-1019-y]
135. Li T, Lu YY, Zhao XD, Guo HQ, Liu CH, Li H, Zhou L, Han YN, Wu KC, Nie YZ, Shi YQ, Fan DM. MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene 2014; 33: 783-793 [PMID: 23353818 DOI: 10.1038/onc.2012.637]
136. Shirin H, Weinstein IB, Moss SF. Effects of H. pylori infection of gastric epithelial cells on cell cycle control. Front Biosci 2001; 6: E104-E118 [PMID: 11578975]
137. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658 [PMID: 17681183 DOI: 10.1053/j.gastro.2007.05.022]
138. Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K, Yamashita J, Saitoh H, Kameoka Y, Shimizu N, Ichinohasama R, Sawada K. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 2009; 114: 3265-3275 [PMID: 19641183 DOI: 10.1182/blood-2009-06-222794]
139. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-14336 [PMID: 17363372 DOI: 10.1074/jbc.M611393200]
140. Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, Lu DS, Zou QM, Xiao B, Mao XH. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 2012; 586: 722-728 [PMID: 22321642 DOI: 10.1016/j.febslet.2012.01.025]
141. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511 [PMID: 15229469 DOI: 10.1038/nri1391]
142. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759 [PMID: 16175180 DOI: 10.1038/nri1703]
143. Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS, Zhao YL, Mao XH, Guo G, Yu PW, Zou QM. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep 2012; 27: 559-566 [PMID: 22020746 DOI: 10.3892/or.2011.1514]
144. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 2012; 11: 71 [PMID: 22992343 DOI: 10.1186/1476-4598-11-71]
145. Hou Z, Xie L, Yu L, Qian X, Liu B. MicroRNA-146a is downregulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol 2012; 29: 886-892 [PMID: 21347720 DOI: 10.1007/s12032-011-9862-7]
146. Hou Z, Yin H, Chen C, Dai X, Li X, Liu B, Fang X. microRNA- 146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Mol Med Rep 2012; 6: 501-506 [PMID: 22711166 DOI: 10.3892/mmr.2012.946]
147. Kogo R, Mimori K, Tanaka F, Komune S, Mori M. Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 2011; 17: 4277-4284 [PMID: 21632853 DOI: 10.1158/1078-0432. CCR-10-2866]
148. Wu K, Yang L, Li C, Zhu CH, Wang X, Yao Y, Jia YJ. MicroRNA- 146a enhances Helicobacter pylori induced cell apoptosis in human gastric cancer epithelial cells. Asian Pac J Cancer Prev 2014; 15: 5583-5586 [PMID: 25081668]
149. Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y. The clinical significance of downregulation of mir-124-3p, mir-146a- 5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 2014; 45: 197-208 [PMID: 24805774 DOI: 10.3892/ ijo.2014.2415]
150. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-7274 [PMID: 18474871 DOI: 10.1073/pnas.0802682105]
151. Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2010; 70: 467-472 [PMID: 19902466 DOI: 10.1002/pros.21080]
152. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010; 15: 524-531 [PMID: 21073609 DOI: 10.1111/j. 1523-5378.2010.00806.x]
153. Song MY, Su HJ, Zhang L, Ma JL, Li JY, Pan KF, You WC. Genetic polymorphisms of miR-146a and miR-27a, H. pylori infection, and risk of gastric lesions in a Chinese population. PLoS One 2013; 8: e61250 [PMID: 23613822 DOI: 10.1371/journal. pone.0061250]
154. Zeng Y, Sun QM, Liu NN, Dong GH, Chen J, Yang L, Wang B. Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol 2010; 16: 3578-3583 [PMID: 20653068]
155. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci 2011; 56: 1131-1137 [PMID: 20721625 DOI: 10.1007/s10620-010-1376-1]
156. Kupcinskas J, Wex T, Link A, Leja M, Bruzaite I, Steponaitiene R, Juzenas S, Gyvyte U, Ivanauskas A, Ancans G, Petrenkiene V, Skieceviciene J, Kupcinskas L, Malfertheiner P. Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer. PLoS One 2014; 9: e87467 [PMID: 24475294 DOI: 10.1371/journal.pone.0087467]
157. Fu B, Song P, Lu M, Wang B, Zhao Q. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis. Biomed Pharmacother 2014; 68: 923-928 [PMID: 25455160 DOI: 10.1016/j.biopha.2014.10.002]
158. Xie WQ, Tan SY, Wang XF. MiR-146a rs2910164 polymorphism increases risk of gastric cancer: a meta-analysis. World J Gastroenterol 2014; 20: 15440-15447 [PMID: 25386093 DOI: 10.3748/wjg. v20.i41.15440]
159. Xu Z, Zhang L, Cao H, Bai B. MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis. BMC Med Genet 2014; 15: 117 [PMID: 25326754 DOI: 10.1186/ s12881-014-0117-2]
160. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647 [PMID: 15766527 DOI: 10.1016/j.cell.2005.01.014]
161. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576-1579 [PMID: 17322030 DOI: 10.1126/science.1137999]
162. Yu J, Feng J, Zhi X, Tang J, Li Z, Xu Y, Yang L, Hu Z, Xu Z. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer. Tumour Biol 2015; 36: 3221-3229 [PMID: 25510669 DOI: 10.1007/s13277-014-2950-5]
163. Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol 2008; 16: 397-405 [PMID: 18619844 DOI: 10.1016/j.tim.2008.05.005]
164. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O'Brien DP, Romero-Gallo J, Peek RM. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 2005; 102: 10646-10651 [PMID: 16027366 DOI: 10.1073/pnas.0504927102]
165. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601 [PMID: 18376396 DOI: 10.1038/ncb1722]
166. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894-907 [PMID: 18381893 DOI: 10.1101/gad.1640608]
167. Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 2012; 19 Suppl 3: S656-S664 [PMID: 22311119 DOI: 10.1245/s10434-012-2 217-6]
168. Chang YJ, Wu MS, Lin JT, Pestell RG, Blaser MJ, Chen CC. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell Microbiol 2006; 8: 1740-1752 [PMID: 16759223 DOI: 10.1111/j.1462-5822.2006.00743.x]
169. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T, Si J. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 2009; 44: 556-561 [PMID: 19363643 DOI: 10.1007/ s00535-009-0037-7]
170. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47: 1955-1963 [PMID: 18433021 DOI: 10.1002/hep.22256]
171. Ye F, Tang C, Shi W, Qian J, Xiao S, Gu M, Dang Y, Liu J, Chen Y, Shi R, Zhang G. A MDM2-dependent positive-feedback loop is involved in inhibition of miR-375 and miR-106b induced by Helicobacter pylori lipopolysaccharide. Int J Cancer 2015; 136: 2120-2131 [PMID: 25307786 DOI: 10.1002/ijc.29268]
172. Miao L, Liu K, Xie M, Xing Y, Xi T. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling. Cancer Immunol Immunother 2014; 63: 699-711 [PMID: 24718681 DOI: 10.1007/s00262-014-1550-y]
173. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010; 70: 2339-2349 [PMID: 20215506 DOI: 10.1158/0008-5472. CAN-09-2777]
174. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, Selaru FM, Hamilton JP, Yang J, Abraham JM, Mori Y, Meltzer SJ. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700 [PMID: 19422085]
175. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cellcycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-286 [PMID: 18328430 DOI: 10.1016/j.ccr.2008.02.013]
176. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, Kim VN. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-1681 [PMID: 19153141 DOI: 10.1093/nar/gkp002]
177. Nishizawa T, Suzuki H. The role of microRNA in gastric malignancy. Int J Mol Sci 2013; 14: 9487-9496 [PMID: 23629677 DOI: 10.3390/ijms14059487]
178. Lai KW, Koh KX, Loh M, Tada K, Subramaniam MM, Lim XY, Vaithilingam A, Salto-Tellez M, Iacopetta B, Ito Y, Soong R. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 2010; 46: 1456-1463 [PMID: 20176475 DOI: 10.1016/j.ejca.2010.01.036]
179. Suzuki M, Suzuki H, Minegishi Y, Ito K, Nishizawa T, Hibi T. H. pylori-Eradication Therapy Increases RUNX3 Expression in the Glandular Epithelial Cells in Enlarged-Fold Gastritis. J Clin Biochem Nutr 2010; 46: 259-264 [PMID: 20490322 DOI: 10.3164/ jcbn.09-127]
180. Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu Y, Gu Q, Zhu Z, Liu B. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48: 1023-1033 [PMID: 23338485 DOI: 10.1007/s00535-012-0733-6]
181. Chen L, Zhang W, Yan W, Han L, Zhang K, Shi Z, Zhang J, Wang Y, Li Y, Yu S, Pu P, Jiang C, Jiang T, Kang C. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Carcinogenesis 2012; 33: 2276-2282 [PMID: 22871495 DOI: 10.1093/carcin/bgs261]
182. Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH, Friis- Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011; 10: 29 [PMID: 21418558 DOI: 10.1186/1476-4598-10-29]
183. Zhou X, Xu G, Yin C, Jin W, Zhang G. Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget 2014; 5: 11631-11640 [PMID: 25373785]
184. Xu X, Li W, Fan X, Liang Y, Zhao M, Zhang J, Liang Y, Tong W, Wang J, Yang W, Lu Y. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene 2007; 26: 7371-7379 [PMID: 17525738 DOI: 10.1038/sj.onc.1210538]
185. Cui Y, Su WY, Xing J, Wang YC, Wang P, Chen XY, Shen ZY, Cao H, Lu YY, Fang JY. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer. PLoS One 2011; 6: e25872 [PMID: 21998710 DOI: 10.1371/journal.pone.0025872]
186. Saito Y, Suzuki H, Imaeda H, Matsuzaki J, Hirata K, Tsugawa H, Hibino S, Kanai Y, Saito H, Hibi T. The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int J Cancer 2013; 132: 1751-1760 [PMID: 23001726 DOI: 10.1002/ijc.27862]
187. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-6140 [PMID: 17404574 DOI: 10.1038/sj.onc.1210436]
188. Guo JX, Tao QS, Lou PR, Chen XC, Chen J, Yuan GB. miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev 2012; 13: 2263-2267 [PMID: 22901205]
189. Leung WK, To KF, Chu ES, Chan MW, Bai AH, Ng EK, Chan FK, Sung JJ. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 2005; 92: 2190-2194 [PMID: 15942635 DOI: 10.1038/sj.bjc.6602636]
190. Gu P, Xing X, Tänzer M, Röcken C, Weichert W, Ivanauskas A, Pross M, Peitz U, Malfertheiner P, Schmid RM, Ebert MP. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Neoplasia 2008; 10: 563-572 [PMID: 18516293]
191. Li BS, Zhao YL, Guo G, Li W, Zhu ED, Luo X, Mao XH, Zou QM, Yu PW, Zuo QF, Li N, Tang B, Liu KY, Xiao B. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 2012; 7: e41629 [PMID: 22860003 DOI: 10.1371/journal.pone.0041629]
192. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, Daiming F. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-833 [PMID: 21628394 DOI: 10.1158/1541-7786. MCR-10-0529]
193. Ma L, Chen Y, Zhang B, Liu G. Increased microRNA-223 in Helicobacter pylori-associated gastric cancer contributed to cancer cell proliferation and migration. Biosci Biotechnol Biochem 2014; 78: 602-608 [PMID: 25036956 DOI: 10.1080/09168451.2014.8956 61]
194. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 2002; 277: 26729-26732 [PMID: 12048180 DOI: 10.1074/jbc.C200256200]
195. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR- 27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009; 284: 23204-23216 [PMID: 19574223 DOI: 10.1074/jbc. M109.031427]
196. Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009; 273: 233-242 [PMID: 18789835 DOI: 10.1016/ j.canlet.2008.08.003]
197. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009; 24: 652-657 [PMID: 19175831 DOI: 10.1111/j.1440-1746.2008.05666. x]
198. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 2012; 69: 723-731 [PMID: 21993663 DOI: 10.1007/ s00280-011-1752-3]
199. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-49 [PMID: 19890957 DOI: 10.1002/cncr.24743]
200. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879 [PMID: 20300657 DOI: 10.1371/journal.pgen.1000879]
201. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78: 113-119 [PMID: 19023205 DOI: 10.1159/000173719]
202. De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 26 Suppl 2: 25-35 [PMID: 18081646 DOI: 10.1111/ j.1365-2036.2007.03475.x]
203. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011; 83: 253-260 [PMID: 21282951 DOI: 10.1159/000280318]
204. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397 [PMID: 18675689 DOI: 10.1016/S0140-6736(08)61159-9]
205. Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H, Inoue K, Uedo N, Iishi H, Haruma K. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer 2013; 109: 2323-2330 [PMID: 24104965 DOI: 10.1038/bjc.2013.596]